We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

High Content Analysis Of Human Pluripotent Stem Cell-Derived Endothelial Cells

Video   Dec 23, 2016

 

Many human vascular diseases are not properly modelled by animal studies and classical cell lines due to the differences in species or the lack of appropriate human cells. The potential of human stem cell-based disease modelling is enhanced by the realisation that vascular cells from human pluripotent stem cells can be obtained with high fidelity. Recent advancement in technology of human pluripotent stem cells has enabled us to generate various new cell types. The development of high-content imaging assays enhances the workflow for understanding progressions and identification of key cellular viability pathways and searching of drug candidates. Results from phenotypic assays with differentiated endothelial cells will be presented.

 
 
 
 

Recommended Videos

Webinar: Improving hepatocyte activity, pooling and lab efficiency

Video

CryostaX® hepatocytes are created using a patented process that produces unique single-donor cell pellets. This format allows for distinct benefits to hepatocyte performance, efficiency in the lab, and test system design, precipitating the potential discontinuation of cryopreserved hepatocytes prepared from traditional methods. This webinar will discuss the technology, its optimal utilization and benefits

WATCH NOW

Why is Cell-by-Cell Analysis Important?

Video

Considerable heterogeneity exists in even the simplest of cell systems. Watch this video to learn why cell-by-cell analysis is important.

WATCH NOW

Signals Notebook: Finally More Time For Science

Video

PerkinElmer Signals Notebook allows you to achieve meaningful scientific breakthroughs – faster and smarter.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE